Sisäpiirin ostoja ei ole viime aikoina paljon näkynyt. CEO-Henrik laittanut kuitenkin nyt kättä taskuun.
1 tykkäys
Pieniä on silakat…
Physitrack Agrees Deal to Launch Digital Rehabilitation Across Major UK Healthcare Provider’s National Network
The deal entails enterprise-wide standardisation across 37 clinical sites and approximately 400 practitioner licences nationwide. Approximately £77,000 in annual recurring subscription revenue, representing an initial deployment with expansion potential as the network grows.
LONDON, UK, June 30, 2026
Physitrack plc (Nasdaq First North: PTRK) today announced an agreement generating approximately £77,000 in annual recurring revenue, standardising digital rehabilitation across 37 clinical sites and approximately 400 practitioner licences for one of the UK’s largest independent healthcare providers, with expansion potential as the network grows.
Highlights:
- Approximately £77,000 in annual recurring revenue, with expansion potential
- 37 clinical sites and approximately 400 practitioner licences nationwide
- An existing ecosystem customer now standardising exclusively on Physitrack across its physiotherapy network
- Controlled implementation expected to commence from H2 2026
… mutta laajennusvaraa on kasvun mukana. Ja valuu hyvällä katteella myös alariville. Otetaan toki vastaan hyvät uutiset 
Edit
toinen soppari heti perään
Physitrack Announces Five-Year Enterprise Agreement with Leading UK Private Hospital Network
Under the agreement, the customer will implement Physitrack across its clinical services on an enterprise-wide basis. Five-year contract valued at approximately £255k over the full term.
LONDON, United Kingdom - June 30, 2026
Physitrack plc (Nasdaq First North: PTRK) today announced a five-year enterprise agreement valued at approximately £255k, including approximately £54k of first-year revenue, deploying 400+ licences across a UK private hospital group of more than 30 hospitals.
Highlights:
- Five-year contract valued at approximately £255k; approximately £54k first-year revenue (including a £36k PhysioTools-to-Physitrack upsell)
- 400+ Physitrack licences across 30+ hospitals
- Branded patient applications and EMR/PMS integration
- Phased migration and revenue recognition through 2026
1 tykkäys
Q2 ulkona
- Kohtuulliset kasvuprosentit, absoluuttisesti kuitenkin maltilliset.
- Kassavirta Q2:lla plussalla, mikä on kuluraskaalla kvartterilla hyvä tilanne
- US markkinan RTM -tuote alkanut tuottamaan liikevaihtoa, tähän lienee isoimmat kasvuodotukset
- Omien ostot aloitetaan, niiden käyttötarkoitus kuitenkin vain johdon palkitsemiseen
Aika kädenlämpöinen raportti 
RTM:n osalta raportilta tavoitteita:
Edit:
Redeye oli hieman positiivisemmalla kannalla
2 tykkäystä
